Mounjaro 2.5mg Injection

Introduction to Mounjaro Injection

Mounjaro Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, a first-in-class dual-incretin therapy. This injection is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus who are unable to achieve adequate glycemic control through oral antidiabetic medications, diet, and exercise.

By mimicking the action of two natural incretin hormones—GLP-1 and GIP—Mounjaro enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower post-meal blood sugar levels and improve overall metabolic control.

Uses of Mounjaro Injection

• Used along with diet and exercise to improve glycemic control in type 2 diabetes.
• Sometimes used off-label for weight management under medical supervision.

Therapeutic Effects

• Stimulates insulin secretion in response to food intake.
• Suppresses glucagon production, reducing liver glucose output.
• Slows down digestion to promote fullness and control calorie intake.
• Supports overall blood sugar regulation and may lead to gradual weight loss.

Storage Information

• Store in a refrigerator (2°C–8°C).
• Do not freeze. Keep away from direct light.
• If a dose is missed, take it within 4 days. Otherwise, skip and wait for the next scheduled dose.